Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1903-1915
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1903
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1903
Y = SFCT, μm | n | β, 95%CI | P value |
Gender | |||
Female | 99 | -0.38 (-2.39 to 1.64) | 0.7157 |
Male | 135 | -2.63 (-4.51 to -0.74) | 0.0074 |
Hypertension history | |||
No | 126 | -1.19 (-2.65 to 0.27) | 0.1137 |
Yes | 108 | -3.27 (-5.42 to -1.12) | 0.0037 |
Education level | |||
Junior high school or below | 147 | -2.13 (-3.90 to -0.36) | 0.0198 |
Senior high school | 40 | -0.72 (-4.44 to 3.00) | 0.7086 |
College or above | 44 | -2.09 (-5.23 to 1.06) | 0.2054 |
Diabetic nephropathy history | |||
No | 188 | -1.76 (-3.06 to -0.46) | 0.0089 |
Yes | 46 | -1.29 (-6.51 to 3.94) | 0.6341 |
Stroke history | |||
No | 222 | -1.48 (-2.80 to -0.16) | 0.0294 |
Yes | 12 | Not applicable | |
Heart disease history | |||
No | 222 | -1.61 (-2.90 to -0.32) | 0.0153 |
Yes | 12 | Not applicable | |
Anemia history | |||
No | 162 | -2.62 (-4.15 to -1.08) | 0.0011 |
Yes | 72 | 1.16 (-1.62 to 3.93) | 0.4176 |
PRP | |||
None | 111 | 0.05 (-1.78 to 1.87) | 0.9602 |
Partial | 43 | -3.64 (-6.62 to -0.66) | 0.0257 |
Whole | 80 | -4.56 (-7.00 to -2.11) | 0.0006 |
Anti-VEGF therapy | |||
No | 175 | -1.03 (-2.56 to 0.50) | 0.1891 |
Yes | 59 | -3.95 (-6.57 to -1.32) | 0.0055 |
Insulin treatment | |||
No | 113 | -1.16 (-2.82 to 0.49) | 0.1711 |
Yes | 121 | -2.34 (-4.42 to -0.25) | 0.0304 |
Oral glucose-lowering drugs | |||
No | 59 | -2.85 (-5.15 to -0.56) | 0.0180 |
Yes | 175 | -2.13 (-3.27 to -0.99) | 0.0003 |
Calcium antagonists | |||
No | 183 | -1.27 (-2.56 to 0.02) | 0.0550 |
Yes | 50 | -3.00 (-7.47 to 1.48) | 0.1993 |
Total cholesterol group (mmol/L) | |||
< 6.22 | 119 | -1.78 (-3.74 to 0.18) | 0.0788 |
≥ 6.22 | 12 | Not applicable | |
eGFR group (mL/minutes × 1.73 m2) | |||
< 30 | 30 | -3.83 (-8.33 to 0.68) | 0.1198 |
≥ 30, < 60 | 61 | -3.45 (-7.12 to 0.22) | 0.0719 |
≥ 60, < 90 | 81 | -1.47 (-4.21 to 1.27) | 0.2976 |
≥ 90 | 62 | 0.11 (-1.87 to 2.08) | 0.9161 |
- Citation: Lei CY, Xie JY, Ran QB, Zhang MX. Non-linear relationship between age and subfoveal choroidal thickness in Chinese patients with proliferative diabetic retinopathy. World J Diabetes 2024; 15(9): 1903-1915
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1903.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1903